Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114667) titled 'The effects of intensive early lipid-lowering and sustained intensive lipid-lowering on atherosclerotic lesion progressin and MACE in patitents with originally diagnosed coronary heart disease- non inferiority, open, randomized controled trial' on Dec. 16, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: TheSeventhAffiliatedHospitalSunYat-senUniversity
Condition:
Coronary heart disease
Intervention:
Intensive early lipid-lowering:Including cholesterol absorption inhibitors, statins, PCSK9 inhibitors, or lipid-lowering drugs such as inclisiran, a small interfering RNA.
Recruit...